Canterbury DHB

Context

Aplastic Anaemia

The standard conditioning for Stem Cell Transplant in Aplastic Anaemia is Cyclophosphamide 50 mg/kg/day for 4 days and ATG.

Alemtuzumab (Campath)

This too can be added to cyclophosphamide as part of the conditioning schedule usually with the aim of decreasing the risk of GvHD. It is never combined with ATG. The use of alemtuzumab remains experimental - seek advice from the Consultant.

About this Canterbury DHB document (9194):

Document Owner:

Andrew Butler (see Who's Who)

Issue Date:

December 2016

Next Review:

December 2018

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9194